GLAXAL BASE

The Secret

FIND A DERMATOLOGIST
SKIN CARE

Glaxal Base® has been marketed in Canada for over 40 years.

Glaxal Base® was initially developed as a base or carrier for compounded pharmaceuticals by Pharmacist in Canada in response to physician prescriptions for specialty topical pharmaceuticals. Over time, pharmacists began to recommend Glaxal Base® to consumers seeking a product to treat dry skin and related conditions. This trend has continued and today Glaxal Base® is the skin moisturizer recommended most by Canadian pharmacists.

In the past few years, other uses for Glaxal Base® cream have emerged including the moisturizing of skin distressed by treatments. With regard to Glaxal Base® Moisturizing Cream, the skin moisturizing properties of this product were recognized by radiation therapists as beneficial to their patients. Over time, the use of Glaxal Base® Moisturizing Cream as a moisturizer has been recommended by Radiation Oncology Centers across Canada.

Reports from various Canadian Radiation Centers document their recommendation of Glaxal Base® Moisturizing Cream. By and large they recommend Glaxal Base® Moisturizing Cream to their patients.

In the Over the Counter Counselling and Recommendation Survey conducted by industry magazines Drugstore Canada and L'actualité pharmaceutique, Glaxal Base® was voted the number-one choice in the Moisturizer/Dry Skin category. In taking these top honors, Glaxal Base® Moisturizing Cream and Glaxal Base™ Moisture Therapy Lotion are widely acknowledged as standard moisturizers for skin that’s undergone harsh treatments as well as everyday dry, itchy skin conditions. Glaxal Base® is one of the many quality over-the-counter products offered by the privately-held WellSpring Pharmaceutical Corporation.

The WellSpring Corporate philosophy embraces enduring excellence in its production of popular niche products. The Company recognizes and invests in the therapeutic value of unique pharmaceutical products used in the treatment of cancer, metabolic and cardiovascular disease and certain neonatology disorders. At WellSpring, we believe no one should be denied the best treatment options.